SYNCOM FORMULATIONS (INDIA)
|
The Current P/S Ratio of SYNCOM FORMULATIONS (INDIA) is 4.21.
Share Price | ₹11.2 | Mar 28,2024 |
Market Cap | ₹1,050.9 Cr | |
Sales-TTM | ₹249.8 Cr | TTM-Consolidated Results |
Price/Sales | 4.21x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SYNCOM FORMULATIONS (INDIA)
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,050.9 Cr] as on Mar 28,2024
(/) Sales [ ₹249.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.21x ]
Thus, for SYNCOM FORMULATIONS (INDIA) , the investors are currently willing to pay '4.21 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SYNCOM FORMULATIONS (INDIA) !
The chart below summarizes the trend in P/S Ratio of SYNCOM FORMULATIONS (INDIA) over the last five years.
Historical PS (Price/Sales) ratio chart of SYNCOM FORMULATIONS (INDIA)
PS Ratio Performance Analysis for SYNCOM FORMULATIONS (INDIA)
- SYNCOM FORMULATIONS (INDIA) 's p/e ratio for fiscal years ending Mar2023 to Mar2015 averaged 2.07x.
- SYNCOM FORMULATIONS (INDIA) 's operated at median p/e ratio of 1.93x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SYNCOM FORMULATIONS (INDIA) 's p/e ratio peaked in Mar2022 at 4.17x.
- SYNCOM FORMULATIONS (INDIA) 's p/e ratio hit its five-year low in Mar2017 of 0.83x.
How does SYNCOM FORMULATIONS (INDIA) 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SYNCOM FORMULATIONS (INDIA) | 249.8 | 4.21 | 1,050.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 8.20 | 388,812.0 |
CIPLA LTD | 25,350.2 | 4.76 | 120,673.0 |
DR REDDYS LABORATORIES LTD | 27,212.5 | 3.77 | 102,679.0 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 5.32 | 101,152.0 |
DIVIS LABORATORIES LTD | 7,492.8 | 12.18 | 91,234.9 |
MANKIND PHARMA LTD | 9,946.3 | 9.25 | 92,029.2 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.41 | 88,034.7 |
LUPIN LTD | 19,480.1 | 3.78 | 73,722.0 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.29 | 63,835.1 |
ABBOTT INDIA LTD | 5,753.4 | 9.95 | 57,258.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SYNCOM FORMULATIONS (INDIA) 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.29x |
Max industry PS | 12.18x |
Median industry PS | 5.32x |
Average industry PS | 6.56x |
You may also like the below Video Courses